These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18752509)

  • 21. Latanoprost systemic exposure in pediatric and adult patients with glaucoma: a phase 1, open-label study.
    Raber S; Courtney R; Maeda-Chubachi T; Simons BD; Freedman SF; Wirostko B;
    Ophthalmology; 2011 Oct; 118(10):2022-7. PubMed ID: 21788077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo.
    Pellinen P; Huhtala A; Tolonen A; Lokkila J; Mäenpää J; Uusitalo H
    Curr Eye Res; 2012 Feb; 37(2):145-54. PubMed ID: 22049909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Optimization of benzalkonium chloride concentration in 0.0015% tafluprost ophthalmic solution from the points of ocular surface safety and preservative efficacy].
    Asada H; Takaoka-Shichijo Y; Nakamura M; Kimura A
    Yakugaku Zasshi; 2010 Jun; 130(6):867-71. PubMed ID: 20519865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of preservative-free 0.0015% tafluprost in glaucoma patients: a prospective crossover study.
    Lee W; Lee S; Bae H; Kim CY; Seong GJ
    BMC Ophthalmol; 2017 Apr; 17(1):61. PubMed ID: 28454526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tafluprost: a novel prostaglandin analog for treatment of glaucoma.
    Pantcheva MB; Seibold LK; Awadallah NS; Kahook MY
    Adv Ther; 2011 Sep; 28(9):707-15. PubMed ID: 21858491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of SofZia-preserved travoprost and benzalkonium chloride-preserved latanoprost on the ocular surface -- a multicentre randomized single-masked study.
    Aihara M; Oshima H; Araie M;
    Acta Ophthalmol; 2013 Feb; 91(1):e7-e14. PubMed ID: 23241328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line.
    Brasnu E; Brignole-Baudouin F; Riancho L; Guenoun JM; Warnet JM; Baudouin C
    Curr Eye Res; 2008 Apr; 33(4):303-12. PubMed ID: 18398704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Efficacy of Benzalkonium Chloride-optimized Tafluprost in Japanese Glaucoma Patients With Existing Superficial Punctate Keratitis.
    Suzuki K; Teranishi S; Sagara T; Yoshino H; Nakayama M; Enoki M; Nuno Y; Hirano S; Wakuta M; Takahashi N; Tokuhisa K; Kondo Y; Shiraishi R; Ishida Y; Sonoda KH;
    J Glaucoma; 2015 Aug; 24(6):e145-50. PubMed ID: 24240881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tafluprost--a novel prostaglandin F2alpha analogue].
    Petrov SIu
    Vestn Oftalmol; 2014; 130(5):85-95. PubMed ID: 25711069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
    Ammar DA; Noecker RJ; Kahook MY
    Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost.
    Aihara M; Otani S; Kozaki J; Unoki K; Takeuchi M; Minami K; Miyata K
    J Glaucoma; 2012 Jan; 21(1):60-4. PubMed ID: 21278589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and ocular surface tolerability of preservative-free tafluprost 0.0015%: a 6-month, single-blind, observational study on naïve ocular hypertension or glaucoma patients.
    Rossi GC; Pasinetti GM; Raimondi M; Ricciardelli G; Scudeller L; Blini M; Amisano A; Bianchi PE
    Expert Opin Drug Saf; 2012 Jul; 11(4):519-25. PubMed ID: 22690824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of preservative-free tafluprost on keratocytes, sub-basal nerves, and endothelium: a single-blind one-year confocal study on naïve or treated glaucoma and hypertensive patients versus a control group.
    Rossi GC; Blini M; Scudeller L; Ricciardelli G; Depolo L; Amisano A; Bossolesi L; Pasinetti GM; Bianchi PE
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):821-5. PubMed ID: 23944905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness.
    Hommer A; Schmidl D; Kromus M; Bata AM; Fondi K; Werkmeister RM; Baar C; Schmetterer L; Garhöfer G
    Eur J Ophthalmol; 2018 Jul; 28(4):385-392. PubMed ID: 29592773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety evaluation of benzalkonium chloride preserved eye-drops compared with alternatively preserved and preservative-free eye-drops in the treatment of glaucoma: a systematic review and meta-analysis.
    Hedengran A; Steensberg AT; Virgili G; Azuara-Blanco A; Kolko M
    Br J Ophthalmol; 2020 Nov; 104(11):1512-1518. PubMed ID: 32051133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism and ocular tissue distribution of an antiglaucoma prostanoid, tafluprost, after ocular instillation to monkeys.
    Fukano Y; Kawazu K; Akaishi T; Bezwada P; Pellinen P
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):251-9. PubMed ID: 21491995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
    Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
    Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and tolerability of the tafluprost/timolol fixed combination for the treatment of glaucoma.
    Holló G; Katsanos A
    Expert Opin Drug Saf; 2015 Apr; 14(4):609-17. PubMed ID: 25640746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy.
    Lewis RA; Katz GJ; Weiss MJ; Landry TA; Dickerson JE; James JE; Hua SY; Sullivan EK; Montgomery DB; Wells DT; Bergamini MV;
    J Glaucoma; 2007 Jan; 16(1):98-103. PubMed ID: 17224758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative, placebo-controlled study of prostanoid fluoroprostaglandin-receptor agonists tafluprost and latanoprost in healthy males.
    Sutton A; Gilvarry A; Ropo A
    J Ocul Pharmacol Ther; 2007 Aug; 23(4):359-65. PubMed ID: 17803434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.